BioLife Solutions, Inc. announced that it has entered into a Securities Purchase Agreement with returning investor, Casdin Partners Master Fund, L.P. managed by Casdin Capital, LLC that it has issued 927,165 shares of common stock of the Company, par value $0.001 per share at a purchase price of $11.19 per share for an aggregate gross proceeds of $10,374,976.35 on October 19, 2023. After completion of the Private Placement, the Purchaser will own approximately 19.5% of the Company?s outstanding common stock. The Purchase Agreement includes customary representations, warranties and covenants from the Company and the Purchaser.

The company has received $10,374,976 pursuant to Regulation D and included participation from single investor.